Jeff Yass’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.37M | Sell |
53,198
-157,375
| -75% | -$7.46M | ﹤0.01% | 6090 |
|
|
2026
Q1 | $10.9M | Buy |
210,573
+162,076
| +334% | +$11.3M | ﹤0.01% | 2997 |
|
|
2025
Q4 | $4.47M | Sell |
48,497
-20,831
| -30% | -$1.99M | ﹤0.01% | 4200 |
|
|
2025
Q3 | $5.14M | Buy |
69,328
+51,299
| +285% | +$5.19M | ﹤0.01% | 4043 |
|
|
2025
Q2 | $2.34M | Buy |
18,029
+9,522
| +112% | +$1.38M | ﹤0.01% | 5454 |
|
|
2025
Q1 | $1.35M | Buy |
8,507
+5,826
| +217% | +$1.05M | ﹤0.01% | 6478 |
|
|
2024
Q4 | $497K | Sell |
2,681
-4,510
| -63% | -$875K | ﹤0.01% | 8679 |
|
|
2024
Q3 | $1.52M | Buy |
7,191
+115
| +2% | +$20K | ﹤0.01% | 5883 |
|
|
2024
Q2 | $947K | Buy |
7,076
+4,686
| +196% | +$887K | ﹤0.01% | 6717 |
|
|
2024
Q1 | $513K | Sell |
2,390
-1,613
| -40% | -$316K | ﹤0.01% | 8451 |
|
|
2023
Q4 | $814K | Sell |
4,003
-101,724
| -96% | -$16.5M | ﹤0.01% | 7486 |
|
|
2023
Q3 | $21M | Sell |
105,727
-81,763
| -44% | -$20.6M | ﹤0.01% | 1692 |
|
|
2023
Q2 | $60.9M | Buy |
187,490
+158,390
| +544% | +$45.3M | 0.01% | 869 |
|
|
2023
Q1 | $6.81M | Buy |
29,100
+17,017
| +141% | +$4.3M | ﹤0.01% | 2993 |
|
|
2022
Q4 | $3.04M | Buy |
12,083
+1,767
| +17% | +$377K | ﹤0.01% | 3999 |
|
|
2022
Q3 | $1.83M | Buy |
10,316
+5,898
| +133% | +$1.19M | ﹤0.01% | 5097 |
|
|
2022
Q2 | $807K | Buy |
4,418
+965
| +28% | +$192K | ﹤0.01% | 7049 |
|
|
2022
Q1 | $886K | Buy |
3,453
+207
| +6% | +$47.3K | ﹤0.01% | 7433 |
|
|
2021
Q4 | $747K | Sell |
3,246
-9,393
| -74% | -$2.29M | ﹤0.01% | 8075 |
|
|
2021
Q3 | $2.94M | Buy |
12,639
+4,925
| +64% | +$1.03M | ﹤0.01% | 4998 |
|
|
2021
Q2 | $1.49M | Buy |
+7,714
| New | +$1.53M | ﹤0.01% | 6657 |
|
|
2021
Q1 | – | Sell |
-14,715
| Closed | -$3.13M | – | 12512 |
|
|
2020
Q4 | $2.77M | Buy |
14,715
+12,098
| +462% | +$1.98M | ﹤0.01% | 4442 |
|
|
2020
Q3 | $338K | Buy |
2,617
+175
| +7% | +$19.3K | ﹤0.01% | 8470 |
|
|
2020
Q2 | $213K | Sell |
2,442
-1,759
| -42% | -$135K | ﹤0.01% | 8928 |
|
|
2020
Q1 | $253K | Buy |
+4,201
| New | +$311K | ﹤0.01% | 8295 |
|
|
2019
Q4 | – | Sell |
-14,288
| Closed | -$918K | – | 10142 |
|
|
2019
Q3 | $872K | Buy |
14,288
+3,878
| +37% | +$255K | ﹤0.01% | 5982 |
|
|
2019
Q2 | $631K | Buy |
10,410
+3,316
| +47% | +$179K | ﹤0.01% | 6762 |
|
|
2019
Q1 | $403K | Buy |
+7,094
| New | +$383K | ﹤0.01% | 6685 |
|
Other funds holding INSP
Jeff Yass's INSP Position: Q2 2026 in Review
Jeff Yass reduced its Inspire Medical Systems (INSP) stake by 75% in Q2 2026, selling an estimated $7.46M and leaving 53,198 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #6090.
Jeff Yass first reported a position in INSP in Q1 2019 and has held it in 28 quarters since. The position peaked at $60.9M in Q2 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- Jeff Yass held 53,198 shares of Inspire Medical Systems worth $2.37M as of Q2 2026.
- Jeff Yass sold 157,375 Inspire Medical Systems shares in Q2 2026, an estimated $7.46M.
- Inspire Medical Systems made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #6090 holding.
- Jeff Yass first reported a position in Inspire Medical Systems in Q1 2019 and has held it in 28 quarters since.
- Jeff Yass's Inspire Medical Systems position peaked at $60.9M in Q2 2023.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.